Dr. Harold O. Longe, MD

Dr. Longe practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Longe's NPI, 1326039272, was assigned on October 31, 2005. Dr. Longe graduated from University of Ilorin Faculty of Health Sciences in 1988. Dr. Longe's Indiana license number on file is 01066368A.

Dr. Longe's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Longe's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Longe is also affiliated with IU Health Ball Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Longe to 2 more hospitals and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Longe practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Longe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Longe is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Longe's licenses on file in 4 states: Indiana, Massachusetts, Arkansas and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Longe treats.

CMS data shows 1,081 Medicare services from Dr. Longe across 7 procedure codes in 2024, for 269 Medicare patients. Medicare paid $83,200 for them.

CMS counts 269 Medicare patients who saw Dr. Longe in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Longe's median patient age at 64, with 64% women.

In 2024, Dr. Longe wrote 1,586 Medicare Part D claims for 209 patients. 71% of them were for generic drugs. CMS names the drug for 1,367 of them, across 39 drugs with 11 or more claims each, at $2,212,050 in total drug cost. In 2023, CMS named 1,424 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Longe for performance year 2024, reported individually. Dr. Longe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Longe as offering telehealth.

Dmand AI links 3 papers to Dr. Longe, published from 2018 to 2022.

Dmand AI links Dr. Longe to 1 clinical trial. Conditions studied include Carcinoma, Transitional Cell and Urinary Bladder Neoplasms.

CMS Open Payments shows 80 general payments to Dr. Longe from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $206.

Dr. Longe graduated from University of Ilorin Faculty of Health Sciences in 1988.

Dr. Longe is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.